South Korea’s response to the pandemic has been widely praised, achieving success through rigorous preparation, rapid response for detection and appropriate containment and treatment, with almost immediate access to PCR tests.
Leading South Korea’s innovative biotechnology industry is Seegene, a world leader in molecular diagnostics, specialising in multiplex polymerase chain reaction (PCR) assays since 2000. As a global pioneer in the in vitro diagnostic (IVD) market, its innovative patented molecular technologies and integrated automation solutions have resulted in Seegene being pivotal in providing molecular IVD solutions across Europe, with in excess of 1000 platforms being used routinely for enteric, respiratory, sexually transmitted infection (STI) and human papillomavirus (HPV) screening.
Since early on in the pandemic, Seegene has been a regular focus of the world press including CNN, ABC and the BBC, for its ability to rapidly develop and manufacture real-time PCR test kits for COVID-19. So, how did Seegene do it?
31 December 2019
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.